mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.6 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |